Skip to search formSkip to main contentSkip to account menu

beractant

Known as: beractant [Chemical/Ingredient], surfactant-TA 
National Institutes of Health

Related topics

Related topics

8 relations

Broader (2)

Biological ProductsPulmonary Surfactants
Drug AllergyPreterm InfantRespiratory Distress Syndrome, NewbornSurfactant Activity [MoA]

Narrower (1)

Survanta

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome
Abstract Objective: To assess the impact of beractant treatment using the less invasive surfactant administration (LISA… 
2019
2019
Effect of two different early rescue surfactant treatments on mortality in preterm infants with respiratory distress syndrome
Although current evidence suggests that initial dose of 200 mg/kg poractant alfa reduces mortality in the treatment of… 
2018
2018
Poractant Alfa Versus Beractant for Neonatal Respiratory Distress Syndrome: A Retrospective Cost Analysis.
OBJECTIVES The objectives of this study were to determine the average medication cost per patient of poractant alfa and beractant… 
2015
2015
Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome.
2009
2009
Effects of beractant and poractant administration on cerebral hemodynamics
Objective: To determine whether type and timing of surfactant preparation affect cerebral blood flow (CBF) hemody- namics… 
2009
2009
Reducing neonatal mortality in developing countries: low-cost interventions are the key determinants
Reducing neonatal mortality in developing countries: low-cost interventions are the key determinants 
Review
2004
Review
2004
Comparison of beractant and calfactant in a neonatal intensive care unit.
PURPOSE The relative efficacy, complications and cost of beractant and calfactant were studied. METHODS All patients admitted… 
2001
2001
Early administration of the second dose of surfactant (beractant) in the treatment of severe hyaline membrane disease
The aim of this study was to demonstrate that administration of the second dose of beractant 2 h after the first one is more… 
Highly Cited
1996
Highly Cited
1996
Comparative Effects of Some Serum Components and Proteolytic Products of Fibrinogen on Surface Tension-Lowering Abilities of Beractant and a Synthetic Peptide Containing Surfactant KL41
The serum components of C-reactive protein, lysophosphatidylcholine, fibrinogen, and fibrinogen proteolytic products have been… 
1993
1993
Cost Effectiveness of Beractant in the Prevention of Respiratory Distress Syndrome
SummaryBeractant, a modified natural bovine surfactant extract, has been used successfully in the prevention of respiratory… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)